Prospective randomly controlled trial of three antibiotic combinations for empirical therapy of suspected sepsis in neutropenic cancer patients
- PMID: 767119
- DOI: 10.1016/b978-0-08-019964-1.50005-1
Prospective randomly controlled trial of three antibiotic combinations for empirical therapy of suspected sepsis in neutropenic cancer patients
Similar articles
-
Protocol for an international prospective trial of initial therapy regimens in neutropenic patients with malignant disease.Eur J Cancer (1965). 1975 Aug;11suppl:1-4. doi: 10.1016/b978-0-08-019964-1.50004-x. Eur J Cancer (1965). 1975. PMID: 767118 Clinical Trial. No abstract available.
-
Empirical antibiotic therapy in febrile patients with neutropenia and malignant disease.Eur J Cancer (1965). 1973 Jun;9(6):417-23. doi: 10.1016/0014-2964(73)90106-0. Eur J Cancer (1965). 1973. PMID: 4372049 No abstract available.
-
Tobramycin-cephalothin treatment in leukaemic and neutropenic patients with severe infection.J Antimicrob Chemother. 1977 Jul;3(4):311-5. doi: 10.1093/jac/3.4.311. J Antimicrob Chemother. 1977. PMID: 893240 No abstract available.
-
The use of synergistic combinations of antibiotics in patients with haematological diseases.Clin Haematol. 1976 Jun;5(2):361-77. Clin Haematol. 1976. PMID: 780029 Review. No abstract available.
-
Empirical antibiotic therapy in the febrile neutropenic cancer patient: clinical efficacy and impact of monotherapy.Antimicrob Agents Chemother. 1987 Jul;31(7):971-7. doi: 10.1128/AAC.31.7.971. Antimicrob Agents Chemother. 1987. PMID: 3310871 Free PMC article. Review. No abstract available.